Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$2.00 USD
-0.15 (-6.98%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $1.99 -0.01 (-0.50%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | -0.62 |
Last EPS Surprise | -195.24% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.01 |
Next Year | 0.68 |
EPS (TTM) | -2.02 |
P/E (F1) | 215.00 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 102.00M | 68.00M | 287.00M | 356.00M |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 102.00M | 68.00M | 324.00M | 432.00M |
Low Estimate | 102.00M | 68.00M | 250.00M | 280.00M |
Year ago Sales | 32.44M | 58.72M | 257.24M | 287.00M |
Year over Year Growth Est. | 214.43% | 15.80% | 11.57% | 24.04% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | -0.04 | 0.01 | 0.68 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.05 | -0.04 | 0.01 | 0.68 |
Low Estimate | -0.05 | -0.04 | 0.01 | 0.68 |
Year ago EPS | -0.75 | -0.38 | -1.98 | 0.01 |
Year over Year Growth Est. | 93.33% | 89.47% | 100.51% | 6,700.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.05 | -0.04 | 0.01 | 0.68 |
7 Days Ago | -0.05 | -0.04 | 0.01 | 0.68 |
30 Days Ago | -0.05 | -0.04 | 0.01 | 0.68 |
60 Days Ago | NA | NA | -0.35 | 0.46 |
90 Days Ago | NA | NA | -0.20 | 0.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.04 | 0.01 | 0.68 |
Zacks Consensus Estimate | -0.05 | -0.04 | 0.01 | 0.68 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.62 | -0.27 | -0.38 | -0.75 | NA |
Estimate | -0.21 | -0.21 | -0.52 | -0.61 | NA |
Difference | -0.41 | -0.06 | 0.14 | -0.14 | -0.12 |
Surprise | -195.24% | -28.57% | 26.92% | -22.95% | -54.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more